Emtora Clinical Data to be Highlighted in Podium Presentation at Prestigious 2024 Digestive Disease Week Annual Meeting
Emtora Biosciences, a San Antonio, Texas-based clinical-stage biopharmaceutical company, has been awarded a $16.9M non-dilutive grant from the Cancer Prevention & Research Institute of Texas (CPRIT).